Last updated: February 27, 2026
What is the Drug NDC 69452-0183?
NDC 69452-0183 corresponds to ASPIRIN EC (Enteric-Coated), marketed primarily as an over-the-counter medication used for pain relief, anti-inflammatory purposes, and cardiovascular disease prevention.
Market Landscape
Current Market Size
The global aspirin market was valued at approximately USD 2.3 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% through 2030. The market's expansion is driven by increasing cardiovascular disease prevalence and extensive OTC availability.
Key Players
- Bayer AG
- Johnson & Johnson (Motrin)
- Teva Pharmaceuticals
- Mylan (now part of Viatris)
- Local generics manufacturers globally
Distribution Channels
- Retail pharmacies
- Online OTC platforms
- Hospitals (prescription use in select regions)
Product Differentiation
Aspirin's enteric-coated formulation reduces gastric irritation. Many manufacturers offer branded and generic versions with minimal differentiation, intensifying price competition.
Regulatory Environment
- In U.S., classified as OTC drug under FDA regulations.
- Market approval requires safety and efficacy assessments aligned with OTC monograph requirements.
- Patent considerations are limited due to aspirin’s status as a generic drug, with few recent patent protections.
Pricing Dynamics
Current Pricing
- Wide range depending on packaging and brand.
- Generic aspirin tablets: USD 0.02 to 0.05 per tablet.
- Brand-name enteric-coated formulations: USD 0.10 to 0.20 per tablet.
- Wholesale acquisition cost (WAC) for branded aspirin: approximately USD 8.00– USD 12.00 per bottle of 100 tablets.
Price Trends
- Entry of generics has exerted downward price pressure.
- Retail prices for OTC aspirin remain relatively stable, with minimal inflation.
- Online sales channels have introduced marginally lower prices.
Market Drivers
- Aging populations worldwide increase demand.
- Rising awareness of cardiovascular health.
- Continued generic market penetration stabilizes prices.
- Minimal innovation; market favors low-cost manufacturing.
Price Projections (2023–2030)
| Year |
Estimated Price Range (per tablet) |
Key Factors |
| 2023 |
USD 0.02 – 0.05 |
High generic competition, stable demand |
| 2025 |
USD 0.02 – 0.06 |
Slight inflation, new generic entries |
| 2027 |
USD 0.02 – 0.07 |
Market saturation, patent expirations in some regions |
| 2030 |
USD 0.02 – 0.08 |
Continued generic competition, inflation adjustment |
Price increases remain constrained by price-sensitive OTC markets and the commoditized nature of aspirin.
Competitive Outlook
- No significant premium for enteric-coated variants; cost reductions focus on scale.
- Patent expirations favor generic and store-branded offerings, constraining prices.
- Potential regulatory changes or innovations could alter market dynamics, but none are imminent.
Strategic Implications
Manufacturers focusing on cost efficiency and distribution expansion will sustain margins. Innovators should consider differentiation strategies or value-added formulations to command higher prices, though the market’s low differentiation limits these opportunities.
Key Takeaways
- The aspirin market remains heavily commoditized, with prices stable due to high competition.
- Generics drive the market; branded products command a slight premium.
- Price per tablet is expected to remain within current ranges, with minor upward pressure.
- Market growth is steady, supported by demographic shifts and health initiatives.
- Innovation movement is limited; quality and cost leadership are primary competitive factors.
FAQs
-
What are the main factors influencing aspirin prices?
Market competition, generic availability, manufacturing costs, and demand stability.
-
Are there any regulatory changes affecting aspirin pricing?
Current regulations favor generic proliferation; no significant upcoming changes are anticipated.
-
Can the price of NDC 69452-0183 increase significantly?
Unlikely, given market saturation and price sensitivity. Small increases may occur due to inflation or packaging enhancements.
-
How does the enteric-coated formulation influence market price?
It provides a differentiation point but does not significantly impact pricing due to limited clinical differentiation and prevalent generics.
-
What is the long-term outlook for aspirin pricing?
Prices are expected to remain within current ranges, with minimal fluctuation through 2030.
References
[1] MarketsandMarkets. (2023). "Aspirin Market by Product, Application, and Region."
[2] Statista. (2022). "Global OTC analgesics market size."
[3] FDA. (2023). "OTC Monographs and regulation of aspirin."
[4] IMS Health. (2022). "Pharmaceutical Market Data."
[5] IQVIA. (2022). "Pricing trends in OTC medications."
